drugset / Trial / NCT04112147
A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B
RandomizedParallel-groupTriple-blindTreatment
Summary
Primary Objective: To evaluate the activity of Antroquinonol in patients with chronic hepatitis B Secondary Objective: To assess the mechanism and cytokines change of Antroquinonol in patients with chronic hepatitis B
Timeline
- Start
- 2018-08-10
- Primary completion
- 2020-06-30
- Completion
- 2020-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Antroquinonol | Small molecule | 100 mg | — |
| Subject | Antroquinonol | Small molecule | 200 mg | — |